000			01938 a2200505 4500
005			20250517004538.0
264		0	_c20150803
008			201508s 0 0 eng d
022			_a1872-6968
024	7		_a10.1016/j.clineuro.2014.10.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aIchikawa, Tomotsugu
245	0	0	_aReduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma. _h[electronic resource]
260			_bClinical neurology and neurosurgery _cDec 2014
300			_a106-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCentral Nervous System Neoplasms _xdrug therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKarnofsky Performance Status
650	0	4	_aLymphoma _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aNeuropsychological Tests
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xadministration & dosage
700	1		_aKurozumi, Kazuhiko
700	1		_aMichiue, Hiroyuki
700	1		_aIshida, Joji
700	1		_aMaeda, Yoshinobu
700	1		_aKondo, Eisei
700	1		_aKawasaki, Akihiro
700	1		_aDate, Isao
773	0		_tClinical neurology and neurosurgery _gvol. 127 _gp. 106-11
856	4	0	_uhttps://doi.org/10.1016/j.clineuro.2014.10.011 _zAvailable from publisher's website
999			_c24413330 _d24413330